Study of U3-1402 in subjects with non-small cell lung cancer
U31402-A-U102
Phase 1 other active
Quick answer
Study of U3-1402 in subjects with non-small cell lung cancer for METASTATIC OR UNRESECTABLE NON-SMALL CELL LUNG CANCER is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- METASTATIC OR UNRESECTABLE NON-SMALL CELL LUNG CANCER
- Phase
- Phase 1
- Modality
- other
- Status
- active